Structural insights into the molecular mechanism of high-level ceftazidime–avibactam resistance conferred by CMY-185
Akito Kawai(Fujita Health University), Yohei Doi(Fujita Health University), Christi L. McElheny(University of Pittsburgh), Masahiro Suzuki(Fujita Health University), Samuel A. Shelburne(Hospital Research Foundation), William C. Bachman(University of Pittsburgh), Micah M. Bhatti(The University of Texas MD Anderson Cancer Center), Ryan K. Shields(University of Pittsburgh), Jovan Borjan(The University of Texas MD Anderson Cancer Center), Samuel L Aitken(The University of Texas MD Anderson Cancer Center), William C. Shropshire(The University of Texas MD Anderson Cancer Center)
Cited by 16
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Cloning of a Novel Gene for Quinolone Resistance from a Transferable Plasmid in <i>Shigella flexneri</i> 2b
|Antimicrobial Agents and Chemotherapy|2005|290
Histone-Modifying Complexes Regulate Gene Expression Pertinent to the Differentiation of the Protozoan Parasite <i>Toxoplasma gondii</i>
|Molecular and Cellular Biology|2005|197